VMD Form 4: Director Receives 34,518 RSUs and Records 142,575 Shares

Rhea-AI Filing Summary

Kaushal Nitin, a director of Viemed Healthcare, Inc. (VMD), reported equity awards and increases in beneficial ownership. The filing shows transactions on August 19–20, 2025 in which the reporting person acquired 15,732 common shares and received restricted stock unit grants totaling 34,518 RSUs across two grant dates. One RSU grant from August 20, 2024 vested August 20, 2025 and corresponds to 15,732 shares; a separate RSU grant on August 19, 2025 vests August 19, 2026 for 18,786 shares. Following the reported transactions, the filing lists 142,575 common shares as beneficially owned by the reporting person. The form is signed by an attorney-in-fact.

Positive

• Director received equity compensation in the form of RSU grants (15,732 and 18,786 RSUs) demonstrating alignment with shareholders
• Beneficial ownership increased to 142,575 common shares following reported transactions, clearly disclosed on the Form 4
• RSU grant and vesting dates are specified (vest dates: 08/20/2025 and 08/19/2026), allowing precise tracking of future dilution timing

Negative

• None.

Insights

Securities Analyst

TL;DR: Director received RSU grants and recorded an increase in beneficial ownership to 142,575 shares.

The Form 4 documents standard equity compensation activity for a company director. The reporting person was granted restricted stock units on two dates and shows an acquisition of 15,732 common shares in connection with a vesting event. These entries reflect compensation-related equity issuance rather than open-market trading. The filing clearly states vesting dates for the RSU grants and the conversion equivalence of one RSU to one common share, allowing investors to quantify potential future dilution when RSUs vest and convert.

Corporate Governance Expert

TL;DR: Director equity awards disclosed; documentation includes grant and vesting dates and beneficial ownership total.

The disclosure identifies the reporting person as a director and provides explicit grant dates and vesting schedules for RSUs: a grant from August 20, 2024 that vested August 20, 2025 and a grant on August 19, 2025 that vests August 19, 2026. The Form 4 shows the total beneficial ownership after reported transactions, which is useful for assessing insider alignment with shareholders. The filing is properly executed by an attorney-in-fact and contains explanatory remarks tying RSUs to common shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kaushal Nitin

(Last) (First) (Middle)

625 E. KALISTE SALOOM RD.

(Street)

LAFAYETTE LA 70508

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VIEMED HEALTHCARE, INC. [ VMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	08/20/2025		M		15,732	A	(1)	142,575	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/20/2025		M			15,732	(2)	(2)	Common Shares	15,732	$0	0	D
Restricted Stock Units	(1)	08/19/2025		A		18,786		(3)	08/19/2026	Common Shares	18,786	$0	18,786	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.

2. On August 20, 2024, the reporting person was granted Restricted Stock Units which vest on August 20, 2025.

3. On August 19, 2025, the reporting person was granted Restricted Stock Units which vest on August 19, 2026.

Remarks:

	/s/ Jesse Bergeron, Attorney-in-Fact	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Kaushal Nitin report on the Form 4 for VMD?

The filing reports acquisition-related activity: 15,732 common shares acquired and RSU grants totaling 34,518 RSUs with grant dates 08/20/2024 and 08/19/2025.

How many shares does Kaushal Nitin beneficially own after the reported transactions?

The Form 4 lists 142,575 common shares as beneficially owned following the reported transactions.

When do the RSU grants vest according to the filing?

One RSU grant vests on 08/20/2025 (15,732 RSUs) and the other vests on 08/19/2026 (18,786 RSUs).

Do the RSUs convert to common shares, and at what ratio?

Yes. The filing states each Restricted Stock Unit represents a contingent right to receive one common share.

Who signed the Form 4 filing for Kaushal Nitin?

The Form 4 is signed by Jesse Bergeron, Attorney-in-Fact, dated 08/20/2025.